Although AFP is considered the most extensively used serum biomarker for HCC, it is characterized by low sensitivity and specificity in determining HCC lesions even at low-level cutoffs (10–20 ng/mL) [9]. The gene discussed is AFP; the disease is hepatocellular carcinoma.